Search Results 31-40 of 69 for ❌도우미급9:OIO
... 9,1126,#N/A,#N/A 300000354,HC TPMT GENOTPYE,950,#N/A,#N/A 300000355,HC TRB GENE REARRANGE AMPLIFY,751,797.00, 300000357,HC TRG GENE REARRANGEMENT ANALYS ...
Giving more than one drug (combination chemotherapy) and giving the drugs in different doses and in different combinations may kill more cancer cells. It is not ...
Bhakta M, Obioha CC, Sorajja D, Srivathsan K, Arabia FA, Devaleria PA, Jaroszewski DE, Scott LR, Altemose GT. Nontraditional implantable cardioverter ...
About this study. Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) ...
2019 Jan; 9 (1):29-37 Epub 2018 Aug 20. View PubMed; Shiraishi S, Grams MP, Fong de Los Santos LE. Image-guided radiotherapy quality control: Statistical ...
Participation eligibility · ≥18 years of age · TSH > 4.2 mIU/L (normal TSH acceptable if patient is already on levothyroxine) · TPO antibodies >9 IU/L or ULN for ...
The purpose of this study is to show that acute, rapid, revascularization in patients with acute ischemic stroke due to medium vessel occlusion (MeVO) results ...
This randomized phase II trial studies how well metformin hydrochloride and combination chemotherapy works in treating patients with stage III-IV ovarian, ...
These antidepressants may help if other treatments fail. If you take them, stay away from certain foods and medicines to prevent serious side effects.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.